Spots Global Cancer Trial Database for recombinant interferon gamma
Every month we try and update this database with for recombinant interferon gamma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002761 | Leukemia | filgrastim recombinant int... busulfan cyclophosphamid... cyclosporine cytarabine idarubicin peripheral bloo... | 18 Years - 60 Years | Columbia University | |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | NCT00002796 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | fluorouracil sodium phenylbu... indomethacin recombinant int... | - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | NCT00059878 | Infection Unspecified Adu... | recombinant int... voriconazole | 2 Years - | National Cancer Institute (NCI) | |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | NCT00002796 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | fluorouracil sodium phenylbu... indomethacin recombinant int... | - | National Cancer Institute (NCI) | |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | NCT00004016 | Melanoma (Skin) Unspecified Adu... | recombinant int... | 18 Years - | University of Rochester | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002761 | Leukemia | filgrastim recombinant int... busulfan cyclophosphamid... cyclosporine cytarabine idarubicin peripheral bloo... | 18 Years - 60 Years | Columbia University | |
| Biological Therapy in Treating Patients With Prostate Cancer | NCT00002637 | Prostate Cancer | aldesleukin gene-modified t... recombinant int... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Tumor Cell Vaccine in Treating Patients With Advanced Cancer | NCT00002505 | Unspecified Adu... | filgrastim recombinant int... tumor cell lysa... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer | NCT00004032 | Recurrent Ovari... | ALVAC-hB7.1 recombinant int... laboratory biom... | - | National Cancer Institute (NCI) | |
| Tumor Cell Vaccine in Treating Patients With Advanced Cancer | NCT00002505 | Unspecified Adu... | filgrastim recombinant int... tumor cell lysa... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00006113 | Melanoma (Skin) | MART-1 antigen aldesleukin gp100 antigen recombinant CD4... recombinant int... recombinant int... sargramostim therapeutic aut... therapeutic tum... tyrosinase pept... Candida albican... | 18 Years - | University of Southern California | |
| Biological Therapy in Treating Patients With Prostate Cancer | NCT00002637 | Prostate Cancer | aldesleukin gene-modified t... recombinant int... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma | NCT00616720 | Multiple Myelom... | aldesleukin idiotype-pulsed... recombinant int... polymerase chai... reverse transcr... flow cytometry laboratory biom... | 18 Years - | Mayo Clinic | |
| Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | NCT00008203 | Breast Cancer | aldesleukin recombinant int... carboplatin cyclophosphamid... cyclosporine thiotepa autologous bone... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma | NCT01957709 | Myxoid Liposarc... Round Cell Lipo... Synovial Sarcom... | Laboratory Biom... Recombinant Int... | 18 Years - | Fred Hutchinson Cancer Center | |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | NCT00004016 | Melanoma (Skin) Unspecified Adu... | recombinant int... | 18 Years - | University of Rochester | |
| Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | NCT00008203 | Breast Cancer | aldesleukin recombinant int... carboplatin cyclophosphamid... cyclosporine thiotepa autologous bone... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
